Early research (Phase 1)Study completedNCT04147819
What this trial is testing
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
Who this might be right for
Cancers With HER2 Expression
Bayer 14